phase readout
saveNCT03360890: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
ACTIVE_NOT_RECRUITINGupdated 2d ago
community read0 votes
Sponsor: University of Chicago. Phase: PHASE2. Conditions: Thyroid Cancer, Salivary Gland Cancer
view source ↗
comments(0)
5-min edit window · permanent after that